Dermatofibrosarcoma Protuberans

7 clinical trials · Condition

Record	Firm	Date
Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger (NCT03381846)	Mayo Clinic	2018-07-01
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma (NCT01154452)	National Cancer Institute (NCI)	2010-06-01
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma (NCT00720174)	National Cancer Institute (NCI)	2008-06-01
AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma (NCT00659360)	National Cancer Institute (NCI)	2008-02-01
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma (NCT00346164)	Children's Oncology Group	2007-02-05
Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans (NCT00243191)	Sarcoma Alliance for Research through Collaboration	2006-05-01
Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans (NCT00084630)	National Cancer Institute (NCI)	2004-05-01

Every clearance here is in the API, with alerts when new ones post.